Roivant Sciences (ROIV) Receivables (2021 - 2024)

Roivant Sciences has reported Receivables for 4 years, with the latest figure at $678000.0 in Q4 2024.

• For the quarter ending Q4 2024, Receivables fell 98.35% year-over-year to $678000.0; the trailing twelve-month figure through Dec 2024 stood at $678000.0 (down 98.35% YoY), and the FY2024 full-year result was $678000.0, down 98.35% from the prior year.
• Receivables for Q4 2024 stood at $678000.0, down from $1.9 million in the prior quarter.
• The five-year high for Receivables was $79.8 million in Q2 2024, with the low at -$96.6 million in Q2 2021.
• Historically, Receivables has averaged $9.2 million across 4 years, with a median of $9.8 million in 2021.
• Annual changes were most pronounced in 2023 — Receivables jumped 683.37% — and 2024, when it slumped 98.35%.
• Roivant Sciences' Receivables stood at $8.9 million in 2021, then surged by 213.5% to $28.0 million in 2022, then surged by 46.88% to $41.1 million in 2023, then tumbled by 98.35% to $678000.0 in 2024.
• The last three Receivables figures came in at $678000.0 (Q4 2024), $1.9 million (Q3 2024), and $79.8 million (Q2 2024), per Business Quant data.